Rio de Janeiro Exhausts Meningitis Vaccine Doses as Temporary Campaign Ends
Rio de Janeiro depleted its municipal supply of the Meningococcal ACWY vaccine by Saturday morning, exhausting doses made available for residents up to 59 years old, O GLOBO reported. The temporary expansion concluded on October 31 across 245 municipal health units, including the city’s three Super Vaccination Centers, with the municipal health department confirming that the deadline will not be extended.
The municipal health department reported administering 450,000 doses over the preceding 25 days, representing a 1,700% increase compared to normal monthly volumes. While shots were available at shopping mall locations such as Nova América in Del Castilho and ParkShoppingCampoGrande in the West Zone following the operating hours of those commercial centers, municipal health secretary Rodrigo Prado stated that the expansion was made possible due to available dose availability, urging individuals to seek immunization before stocks ran out.
National Data Reveals 67.1% Adolescent Vaccination Coverage
Nationwide immunization figures for the target adolescent demographic remain below public health benchmarks. A monitoring dashboard released by the Ministry of Health on Wednesday, October 28, indicates that only 67.1% of youths aged 11 to 14 have received the ACWY dose, falling short of the 95% target cited by VEJA and Metropolises, and the 80% optimal threshold noted by O GLOBO.
Disaggregated data from the federal platform shows coverage varying significantly by age group. Eleven-year-olds record the lowest compliance rate at 46.76%, followed by 71.19% for 12-year-olds, 72.83% for 13-year-olds, and 77.42% for 14-year-olds, according to Metrópoles.
Clinical Guidance on Bacterial Strains and Reinforcement Rules
The Meningococcal ACWY vaccine protects against four serogroups of the bacterium Neisseria meningitidis (A, C, W, and Y), which cause invasive meningococcal disease, manifest as meningitis or meningococcemia, and carry high risks of permanent disability or death. Flávia Bravo, a director at the Brazilian Society of Immunizations (SBIm), emphasized that adolescents act as primary asymptomatic carriers who transmit the bacteria to younger children, adding that municipal vaccine campaigns open to adults up to 59 years old benefit anyone regardless of prior history.
Public health protocols differ between government schedules and private recommendations. Within the Unified Health System (SUS), the ACWY dose serves as a booster at 12 months following initial C-strain doses at 3 and 5 months, and a subsequent dose for adolescents aged 11 to 14, an age expansion that was officially incorporated into the SUS calendar in 2020.
Worth a look